Literature DB >> 10897011

The management and outcome of bladder carcinoma in Ontario, 1982-1994.

C R Hayter1, L F Paszat, P A Groome, K Schulze, W J Mackillop.   

Abstract

BACKGROUND: To the authors' knowledge no previous study has described the management and outcome of bladder carcinoma on a population-based level. The objective of the current study was to describe the characteristics, treatment, and outcome of newly diagnosed invasive bladder carcinoma (n = 20,822) reported in Ontario, Canada between 1982-1994.
METHODS: Electronic records of invasive bladder carcinoma (International Classification of Diseases code 188) from the Ontario Cancer Registry were linked to surgical and radiotherapy (RT) records. Bivariate and multivariate techniques were used to assess variations in the use of initial cystectomy and pelvic RT. The authors modeled the likelihood of death after diagnosis and the probability of cystectomy free survival. All analyses were controlled for age, gender, histology, and year of diagnosis.
RESULTS: The most common histologic type was papillary transitional cell carcinoma. Maximum initial treatment was comprised of total cystectomy (5.1%), partial cystectomy or open excision (3. 5%), pelvic RT (5.9%), transurethral resection of the bladder (66. 7%), or lesser or no procedures (18.7%). The use of total cystectomy and pelvic RT varied among the regions of Ontario. Overall 5-year survival was 58.8%, and was 86.5% for patients with papillary histology. In multivariate analysis, although survival was similar among the regions, the relative risk of cystectomy conditional on survival varied.
CONCLUSIONS: Papillary tumors portend a better survival than nonpapillary tumors. Variations in the use of total cystectomy and in the use of pelvic RT among the regions of Ontario did not appear to be associated with variations in survival. However, cystectomy free survival appeared to vary among the regions. These results suggest that patients can be managed safely using a bladder-preserving approach. Copyright 2000 American Cancer Society.

Entities:  

Mesh:

Year:  2000        PMID: 10897011

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Optimizing care and outcomes of patients with muscle-invasive bladder cancer.

Authors:  Christopher M Booth
Journal:  Can Urol Assoc J       Date:  2013 Sep-Oct       Impact factor: 1.862

2.  Use of radical cystectomy for patients with invasive bladder cancer.

Authors:  John L Gore; Mark S Litwin; Julie Lai; Elizabeth M Yano; Rodger Madison; Claude Setodji; John L Adams; Christopher S Saigal
Journal:  J Natl Cancer Inst       Date:  2010-04-16       Impact factor: 13.506

3.  Non-invasive cardiac stress testing before elective major non-cardiac surgery: population based cohort study.

Authors:  Duminda N Wijeysundera; W Scott Beattie; Peter C Austin; Janet E Hux; Andreas Laupacis
Journal:  BMJ       Date:  2010-01-28

4.  Practice patterns and recurrence after partial cystectomy for bladder cancer.

Authors:  Nader Fahmy; Armen Aprikian; Simon Tanguay; Salaheddin M Mahmud; Mohammed Al-Otaibi; Suganthiny Jeyaganth; Moamen Amin; Wassim Kassouf
Journal:  World J Urol       Date:  2009-10-14       Impact factor: 4.226

5.  Conservative treatment of invasive bladder cancer.

Authors:  N J Rene; F B Cury; L Souhami
Journal:  Curr Oncol       Date:  2009-08       Impact factor: 3.677

Review 6.  Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers.

Authors:  Omar M S El-Taji; Sameer Alam; Syed A Hussain
Journal:  Curr Treat Options Oncol       Date:  2016-03

Review 7.  The Role of Population-Based Observational Research in Bladder Cancer.

Authors:  Andrew G Robinson; Jason P Izard; Christopher M Booth
Journal:  Bladder Cancer       Date:  2015-10-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.